Actavis revealed big time executive payouts for completing a $25 billion agreement to buy Forest Laboratories.
Pharmaceutical mergers can be lucrative, especially for executives.
The $25 billion purchase of Forest Laboratories by Actavis is a case in point, as one standout 8-K filing from last week’s Securities and Exchange Commission data dump revealed.
Help employers find you! Check out all the jobs and post your resume.
